The bill S. 1096, also known as the "Preserve Access to Affordable Generics and Biosimilars Act," aims to prevent brand-name drug companies from paying generic drug companies to delay their cheaper drugs from entering the market. This tactic, known as "reverse payment"...
Simple Explanation
The bill wants to stop big drug companies from paying to keep cheaper, similar drugs away so people can get them sooner and pay less. If companies break the rules, they might get in trouble with the people in charge.